Panel Ranks High-Value, Cost-Effective Preventive Services
By News Staff
9/26/2006
Noting that receipt of evidence-based clinical preventive services "remains discouragingly low for some services and among some population groups," the commission started by prioritizing preventive services that the U.S. Preventive Services Task Force and the CDC's Advisory Committee on Immunization Practices have identified as effective. On a scale from 1 to 5, the commission gave each service a grade for its health impact and a grade for cost-effectiveness. The combined grades ranged from 2 to 10, with the top three items scoring 10. (See chart for top 10 items.)
Steven Woolf, M.D., M.P.H., professor of family medicine, preventive medicine and community health at Virginia Commonwealth University, Fairfax, Va., and Kurt Stange, M.D., Ph.D., professor of family medicine, epidemiology and biostatistics, and oncology and sociology at Case Western Reserve University, Cleveland, served on the 24-member commission and wrote the commentary "A Sense of Priorities for the Healthcare Commons."
"Diseases develop, extant illnesses worsen, and people die prematurely when health care fails to deliver the most effective services," say Woolf and Stange. The commission's rankings "have greatest relevance in the primary care setting," they say. "The rankings provide a rational backdrop for the daily primary care task of matching multiple opportunities with patients' needs and values."
Among advisers to the commission were Herbert Young, M.D., M.A., director of the AAFP Scientific Activities Division. The CDC and the Agency for Healthcare Research and Quality sponsored the project.
One Dose of H1N1 Vaccine Immunogenic in High Percentage of Pregnant Women
FDA Revises Diabetes Drug Prescribing Information
H1N1 Vaccine Availability Increasing Slowly
ACIP Supports 'Permissive Use' of Gardasil in Males
CDC Survey Shows Overall Gains in Teens' Immunization Rates
FDA Approves Gardasil for Males, Bivalent HPV Vaccine for Girls, Women
New USP Standards for Heparin Decrease Unit Dose Potency
H1N1 Vaccine Deliveries Begin This Week
Clinical Trial of H1N1 in Kids, Teens Shows Mixed Results
Physicians Should Use Caution With Tamiflu Dosages
Prostate Cancer Awareness Campaigns Could Cause Confusion
Federal Health Officials Push H1N1 Vaccine for Adults, Health Workers
IOM: N95 Respirators Offer H1N1 Flu Defense for Health Personnel
CDC Updates Recommendations for Antiviral Use
CDC Updates Guidance on Ophthalmia Neonatorum Prophylaxis
New AHRQ Guides Outline Gestational Diabetes Treatment Options
Erythromycin Ophthalmic Ointment in Short Supply
CDC, FDA Study Reinforces Safety, Efficacy of Gardasil
H1N1 Vaccine Clinical Trials in Adults Free of Adverse Events
AAFP Launches Awareness Campaign for Pertussis Vaccination
H1N1 Vaccine Production Lagging Behind Expectations
FDA Issues Multiple Safety Alerts, Updates
Research Network Seeks Evidence to Support Collaborative Care
Vaccines & Immunizations Special Report
ACIP Issues Targeted Recommendations for H1N1 Vaccinations
CDC Pushes Seasonal Flu Shots for Kids Ages 6 Months to 18 Years








